Intra-Cellular Therapies Submits Supplemental New Drug Application to FDA for CAPLYTA for the Treatment of Major Depressive Disorder as Adjunctive Therapy

ITCI Stock  USD 127.33  0.18  0.14%   
Under 55% of Intracellular's traders are presently thinking to get in. The analysis of overall sentiment of trading Intracellular Th stock suggests that some investors are interested at this time. Intracellular's investing sentiment shows overall attitude of investors towards Intracellular Th.
  
The sNDA submission is based on positive results from Studies 501 and 502 demonstrating CAPLYTAs robust antidepressant efficacy and favorable safety and tolerability profileCAPLYTA, if approved as an adjunctive therapy in MDD, would be indicated for the treatment of three different major psychiatry indications affecting over 30 million adult patients in the US BEDMINSTER, N.J., Dec. 03, 2024 -- Intra-Cellular Therapies, Inc. , a biopharmaceutical company focused o

Read at finance.yahoo.com
Yahoo News
  

Intracellular Th Current Investor Sentiment

Panic Vs Confidence

55

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Intracellular's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Intracellular Th.

Intracellular Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Intracellular can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Intracellular Th Historical Investor Sentiment

Investor biases related to Intracellular's public news can be used to forecast risks associated with an investment in Intracellular. The trend in average sentiment can be used to explain how an investor holding Intracellular can time the market purely based on public headlines and social activities around Intracellular Th. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Intracellular's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intracellular and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Intracellular news discussions. The higher the estimate score, the more favorable the investor's outlook on Intracellular.

Intracellular Fundamental Analysis

We analyze Intracellular's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intracellular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intracellular based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Intracellular is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Intracellular Th Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intracellular stock to make a market-neutral strategy. Peer analysis of Intracellular could also be used in its relative valuation, which is a method of valuing Intracellular by comparing valuation metrics with similar companies.

Peers

Intracellular Related Equities

AMRXAmneal Pharmaceuticals,   4.93   
0%
100.0%
PCRXPacira BioSciences,   2.27   
0%
46.0%
ALKSAlkermes Plc   0.83   
0%
16.0%
AQSTAquestive Therapeutics   0.32   
0%
6.0%
CYTHCyclo Therapeutics     
0%
1.0%
NBIXNeurocrine Biosciences   0.20   
4.0%
0%
ANIPANI Pharmaceuticals   0.33   
6.0%
0%
COLLCollegium Pharmaceutical   0.71   
14.0%
0%
AMPHAmphastar   0.83   
16.0%
0%
IRWDIronwood Pharmaceuticals   1.88   
38.0%
0%
DVAXDynavax Technologies   2.05   
41.0%
0%

Complementary Tools for Intracellular Stock analysis

When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments